搜索结果 | 泌尿系统常见疾病循证医学证据

泌尿系统常见疾病循证医学证据

首页搜索结果

证据分类

搜索结果

共搜索到3条与Immunologic/*administration & dosage有关的结果

Intravesical chemohyperthermia versus bacillus calmette-guerin instillation for intermediate- and high-risk non-muscle invasive bladder cancer: A systematic review and meta-analysis

 2021 年发布于 Photodiagnosis Photodyn Ther 127 卷第 7 期

Zhao H. Chan V. W. Castellani D. Chan E. O. Ong W. L. K. Peng Q. Moschini M. Krajewski W. Pradere B. Ng C. Enikeev D. Vasdev N. Ekin G. Sousa A. Leon J. Guerrero-Ramos F. Tan W. Kelly J. Shariat S. F. Witjes J. Teoh J. Y.

Adjuvants Immunologic/*administration & dosage Administration Intravesical BCG Vaccine/*administration & dosage Humans *Lymphocytes Tumor-Infiltrating Treatment Outcome Urinary Bladder Neoplasms/*drug therapy/immunology/*pathology
文献简介 原文链接
Internal double-J stent was associated with a lower incidence of ureteroileal anastomosis stricture than external ureteral catheter for patients undergoing radical cystectomy and orthotopic neobladder: A systematic review and meta-analysis

 2019 年发布于 Anticancer Drugs 98 卷第 1 期

Yang Y. Bai Y. Wang X. Tang Y. Han P. Wei X.

Adjuvants Immunologic/*administration & dosage Administration Intravesical Antineoplastic Agents/therapeutic use BCG Vaccine/*administration & dosage Humans Instillation Drug Randomized Controlled Trials as Topic Urinary Bladder Neoplasms/pathology/*therapy Bacillus Calmette-Guerin Maintenance therapy Non-muscle-invasive bladder cancer Progression Recurrence
文献简介 原文链接
Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis

 2019 年发布于 2018 年浙江省男科学、泌尿外科学学术年会 11 卷第 5 期

Kimura S. Mari A. Foerster B. Abufaraj M. Vartolomei M. D. Stangl-Kremser J. Karakiewicz P. I. Egawa S. Shariat S. F.

Adjuvants Immunologic/*administration & dosage/adverse effects Administration Intravesical Antineoplastic Agents/*administration & dosage/adverse effects BCG Vaccine Carcinoma in Situ/mortality/pathology/*therapy Combined Modality Therapy/adverse effects/methods Disease Progression Drug Administration Schedule Humans Interferon-alpha/*administration & dosage/adverse effects Neoplasm Recurrence Local Randomized Controlled Trials as Topic Time Factors Urinary Bladder Neoplasms/mortality/pathology/*therapy Withholding Treatment/statistics & numerical data
文献简介 原文链接